Walleye Capital
CLB icon

Walleye Capital’s Core Laboratories CLB Stock Holding History

Walleye Capital’s Portfolio CLB Stock Details CLB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$241K Buy
+20,687
New +$295K ﹤0.01% 3355
2024
Q4 		– Sell
-10,993
Closed -$204K – 4922
2024
Q3 		$204K Buy
+10,993
New +$221K ﹤0.01% 3994

Other funds holding CLB

AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DGI
Disciplined Growth Investors Minneapolis, Minnesota $5.91B AUM 53.97% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $141B AUM 34.18% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Walleye Capital's CLB Position: Q2 2026 in Review

Walleye Capital opened a new position in Core Laboratories (CLB) in Q2 2026: 20,687 shares worth $241K. The stake represents ﹤0.01% of the portfolio and ranks #3355 among its holdings. This is a return to the name: Walleye Capital previously reported a position in CLB as recently as Q3 2024.

Walleye Capital first reported a position in CLB in Q3 2024 and has held it in 2 quarters since. 186 funds tracked by Wall St. Rank hold CLB as of Q2 2026.

  • Walleye Capital held 20,687 shares of Core Laboratories worth $241K as of Q2 2026.
  • Core Laboratories was a new Walleye Capital position in Q2 2026.
  • Core Laboratories made up ﹤0.01% of Walleye Capital's portfolio in Q2 2026, its #3355 holding.
  • Walleye Capital first reported a position in Core Laboratories in Q3 2024 and has held it in 2 quarters since.
  • 186 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2026.

Based on Walleye Capital's 13F filing for Q2 2026, filed 3 Aug 2026.